JP2024536088A5 - - Google Patents

Info

Publication number
JP2024536088A5
JP2024536088A5 JP2024518725A JP2024518725A JP2024536088A5 JP 2024536088 A5 JP2024536088 A5 JP 2024536088A5 JP 2024518725 A JP2024518725 A JP 2024518725A JP 2024518725 A JP2024518725 A JP 2024518725A JP 2024536088 A5 JP2024536088 A5 JP 2024536088A5
Authority
JP
Japan
Prior art keywords
nucleic acid
oligonucleotide
target nucleic
target
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518725A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536088A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/044767 external-priority patent/WO2023049477A2/en
Publication of JP2024536088A publication Critical patent/JP2024536088A/ja
Publication of JP2024536088A5 publication Critical patent/JP2024536088A5/ja
Pending legal-status Critical Current

Links

JP2024518725A 2021-09-26 2022-09-26 Mecp2転写物を編集するための組成物及びその方法 Pending JP2024536088A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163248524P 2021-09-26 2021-09-26
US63/248,524 2021-09-26
US202263341391P 2022-05-12 2022-05-12
US63/341,391 2022-05-12
PCT/US2022/044767 WO2023049477A2 (en) 2021-09-26 2022-09-26 Compositions for editing mecp2 transcripts and methods thereof

Publications (2)

Publication Number Publication Date
JP2024536088A JP2024536088A (ja) 2024-10-04
JP2024536088A5 true JP2024536088A5 (cg-RX-API-DMAC7.html) 2025-10-06

Family

ID=85721202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518725A Pending JP2024536088A (ja) 2021-09-26 2022-09-26 Mecp2転写物を編集するための組成物及びその方法

Country Status (6)

Country Link
US (1) US20250135036A1 (cg-RX-API-DMAC7.html)
EP (1) EP4404942A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024536088A (cg-RX-API-DMAC7.html)
AU (1) AU2022349529A1 (cg-RX-API-DMAC7.html)
CA (1) CA3232965A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023049477A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014010250A1 (en) 2012-07-13 2014-01-16 Chiralgen, Ltd. Asymmetric auxiliary group
EP3094728B1 (en) 2014-01-16 2022-03-09 Wave Life Sciences Ltd. Chiral design
CN117965536A (zh) 2015-07-22 2024-05-03 波涛生命科学有限公司 寡核苷酸组合物及其方法
MA46427A (fr) 2015-10-09 2018-08-15 Wave Life Sciences Ltd Compositions d'oligonucléotides et procédés associés
US11013757B2 (en) 2016-06-03 2021-05-25 Wave Life Sciences Ltd. Oligonucleotides, compositions and methods thereof
WO2018098264A1 (en) 2016-11-23 2018-05-31 Wave Life Sciences Ltd. Compositions and methods for phosphoramidite and oligonucleotide synthesis
WO2018237194A1 (en) 2017-06-21 2018-12-27 Wave Life Sciences Ltd. Compounds, compositions and methods for synthesis
CN111108096A (zh) 2017-09-18 2020-05-05 波涛生命科学有限公司 寡核苷酸制备技术
JP2021521140A (ja) 2018-04-12 2021-08-26 ウェイブ ライフ サイエンシズ リミテッドWave Life Sciences Ltd. オリゴヌクレオチド組成物及びその使用方法
CA3098624A1 (en) 2018-05-11 2019-11-14 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof
AU2020241559A1 (en) 2019-03-20 2021-11-11 Wave Life Sciences Ltd. Technologies useful for oligonucleotide preparation
MX2021012981A (es) 2019-04-25 2022-01-18 Wave Life Sciences Ltd Composiciones de oligonucleotido y metodos de uso de las mismas.
CN122555564A (zh) * 2023-09-28 2026-08-11 波涛生命科学有限公司 寡核苷酸组合物及其方法
WO2026055502A2 (en) * 2024-09-05 2026-03-12 Wave Life Sciences Ltd. Inhibin subunit beta e-related double stranded oligonucleotide compositions and methods relating thereto
WO2026077951A1 (en) 2024-10-07 2026-04-16 Vico Therapeutics B.V. Improved aon for rna editing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190626A1 (en) * 2002-04-09 2003-10-09 Vasulinga Ravikumar Phosphorothioate monoester modified oligomers
KR102678809B1 (ko) * 2017-05-18 2024-06-26 더 브로드 인스티튜트, 인코퍼레이티드 표적화된 핵산 편집을 위한 시스템, 방법 및 조성물
US11597744B2 (en) * 2017-06-30 2023-03-07 Sirius Therapeutics, Inc. Chiral phosphoramidite auxiliaries and methods of their use
WO2019084062A1 (en) * 2017-10-23 2019-05-02 The Broad Institute, Inc. SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITION
JP7679311B2 (ja) * 2019-05-21 2025-05-19 ビーム セラピューティクス インク. プログラム可能塩基エディターシステムを用いた一塩基多型編集法
CA3154768A1 (en) * 2019-10-06 2021-04-15 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof
EP4150076A1 (en) * 2020-05-15 2023-03-22 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of methyl-cpg binding protein 2 (mecp2)
JP2023548584A (ja) * 2020-11-08 2023-11-17 ウェイブ ライフ サイエンシズ リミテッド オリゴヌクレオチド組成物及びその方法

Similar Documents

Publication Publication Date Title
JP2023548584A5 (cg-RX-API-DMAC7.html)
US11673911B2 (en) Stabilized nucleic acids encoding messenger ribonucleic acid (mRNA)
AU2014341879B2 (en) Compositions and methods for controlling arthropod parasite and pest infestations
JP2023535918A (ja) Rna編集用のアンチセンスオリゴヌクレオチド
JP2022519019A (ja) オリゴヌクレオチド組成物及びその方法
TW202307207A (zh) 用於抑制黃嘌呤脫氫酶(XDH)之表現之RNAi藥劑、其醫藥組合物及使用方法
BR112021003224A2 (pt) oligonucleotídeos antissentido direcionados a scn2a para o tratamento de encefalopatias por scn1a
HK1255699A1 (zh) Kras表达的调节剂
TW201210611A (en) Treatment of Nicotinamide Phosphoribosyltransferase (NAMPT) related diseases by inhibition of natural antisense transcript to NAMPT
CN108410868A (zh) Gcgr表达的反义调节
EP1141278B1 (en) Therapeutic pde4d phosphodiesterase inhibitors
CN105121452A (zh) 三环核苷和由其制备的寡聚化合物
JP7463621B2 (ja) ミトコンドリアアミドキシム還元成分1(marc1)発現を阻害するための組成物および方法
US20230235329A1 (en) Antisense oligonucleotides (aso) for efficient and precise rna editing with endogenous adenosine deaminase acting on rna (adar)
WO2019181946A1 (ja) 毒性が軽減した核酸
JP7560616B2 (ja) 膜貫通型セリンプロテアーゼ6(tmprss6)発現を阻害するための組成物および方法
JP2021517826A (ja) Gys2発現を阻害するための組成物及び方法
JP7497061B2 (ja) Rna分子、キメラ型na分子、二本鎖rna分子、および二本鎖キメラ型na分子
JP5794559B2 (ja) 間葉系細胞の分化を調節するための薬剤及びその利用
KR20230104880A (ko) 올리고뉴클레오티드의 신경교세포로의 선택적 전달
US20210290653A1 (en) Modulation of lnc05 expression
WO2021177418A1 (ja) Calm2のアンチセンスオリゴヌクレオチド
CN115103911A (zh) 修饰的异源核酸
AU2006345724B2 (en) Compositions and methods for the treatment of muscle wasting
WO2025026228A1 (zh) Cfb抑制剂组合物及其应用